Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
50-35-1
|
| gptkbp:chirality |
R
|
| gptkbp:component |
thalidomide racemate
|
| gptkbp:drugClass |
sedative
immunomodulatory |
| gptkbp:hasEnantiomer |
gptkb:(S)-thalidomide
|
| gptkbp:hasMolecularFormula |
C13H10N2O4
|
| gptkbp:hasSMILES |
O=C1NC(=O)[C@@H](C2=CC=CC3=C2C(=O)NC3=O)CC1
|
| https://www.w3.org/2000/01/rdf-schema#label |
(R)-thalidomide
|
| gptkbp:isomerOf |
gptkb:thalidomide
|
| gptkbp:IUPACName |
(R)-2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione
|
| gptkbp:meltingPoint |
270°C
|
| gptkbp:bfsParent |
gptkb:thalidomide
|
| gptkbp:bfsLayer |
7
|